4th Quarter - Report
THE INGRAM GROUP LLC for ELI LILLY AND COMPANY
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S.2030, Advancing Targeted Therapies for Rare Diseases Act of 2015. H.R.6, 21st Century Cures Act. General issues related to the biopharmaceutical and pharmaceutical industries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEECHER FRASIER | — |
| TOM INGRAM | — |
| DANIEL M MCCARTHY | — |
| JOHN MILNE | — |
| BERNARD TOON | — |
| JEFFREY STUART WIENER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.